INVEST: A phase Ib window of opportunity study of atezolizumab administered either intravesically or direct tumour injection in patients with bladder cancer prior to radical cystectomy. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback